The global Neurofibromatosis Type 2 (NF2) market is witnessing steady growth, driven by increasing awareness of rare genetic disorders, growing adoption of advanced diagnostic tools, and the development of targeted therapies. NF2 is a rare genetic condition characterized by the development of tumors in the nervous system, particularly vestibular schwannomas and meningiomas, leading to hearing...